Pathology
Partner With Us
Advertisement
Conexiant chevron_right Pathology chevron_right CD68 CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma Study
From the Journals

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant
Full Article Summary Notecard
  1. Skeletal Hodgkin lymphoma has a macrophage-rich microenvironment.
  2. High CD68 expression is linked to poorer outcomes.
  3. Chemotherapy regimen studied was ABVD.
  4. 578 genes were analyzed showing differential expression.
  5. Skeletal involvement correlates with worse overall survival.

Source: The Journal of Pathology: Clinical Research

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.